The latest updates on our research and how it is improving people’s lives.
14 October 2019
New research by the Drakesmith group and collaborators shows that BMP inhibitors are able to reverse the main untreatable symptom of the disease.
11 October 2019
Findings reported in The American Journal of Pathology suggest specialized proresolving mediators may become therapeutics that alleviate chronic tendon inflammation
Researchers identify genetic regions associated with left-handedness and link them with brain architecture in language regions
11 September 2019
A new study has for the first time identified regions of the genome associated with left-handedness in the general population and linked their effects with brain architecture. The study linked these genetic differences with the connections between areas of the brain related to language.
3 September 2019
Researchers at the Kennedy Institute identify a molecular pathway to boost vaccine responses in the elderly.
28 August 2019
Professor Daniel Perry was recently Highly Commended in the Vice Chancellors Public Engagement with Research Awards for his work involving parents and children in the research process.
21 August 2019
Oxford is the newest partner of the national Research into Inflammatory Arthritis Centre Versus Arthritis (RACE) which has been awarded continued funding of nearly £2m over the next five years from Versus Arthritis.
1 August 2019
A scheme that pays hospitals to deliver high quality care has been shown to improve the outcomes for patients with broken hips in England.
26 July 2019
Patient Nick Birch climbed Ben Nevis and ran 5K, just a year after having his hip replaced, to raise funds for research and specifically for Professor Siôn Glyn-Jones, the leading consultant on the team.
17 July 2019
New research from a randomised clinical trial published today in The Lancet and funded by the National Institute for Health Research (NIHR) shows that partial knee replacements (PKR) are as good as total knee replacements (TKR), whilst being more cost effective.
2 July 2019
The Kennedy Trust for Rheumatology Research (KTRR) has pledged a minimum of £20M over five years to the Kennedy Institute of Rheumatology at the University of Oxford to support pioneering research into chronic inflammatory disease.
24 June 2019
Researchers at NDORMS and their international partners have been awarded USD1.7 million by the Chan Zuckerberg Initiative (CZI) to unveil the cellular makeup of our healthy tendons. This unprecedented multidisciplinary approach will create the first ever blueprints of healthy tendons from across multiple anatomical sites in the human body.
5 June 2019
A new study by researchers at NDORMS, University of Oxford now published in Osteoarthritis and Cartilage found that the average lifetime risk of needing further surgery following knee and hip replacement – revision surgery – was around 5% after knee replacement and 8% after hip replacement, with neither body mass index (BMI, combining an individual's height and weight) or smoking having any meaningful effect on these risks.
29 May 2019
Pioneering research by scientists at the Universities of Oxford and Birmingham published today in Nature brings us a step closer to developing targeted therapies for inflammatory diseases.
28 May 2019
New research at the Kennedy Institute reveals potential of a novel class of drugs for the treatment of rheumatoid arthritis.
16 May 2019
The Centre for Statistics in Medicine (CSM) has been awarded £2.5m by Cancer Research UK to advance a programme of work for research on research, developing crucial methodology and key guidelines for excellent medical research.
7 May 2019
Dr Fiona Watt has been awarded a prestigious UK Research and Innovation (UKRI) Future Leaders Fellowship to further her research for better treatments for people living with, or at risk of the commonest form of arthritis, osteoarthritis.
18 April 2019
A recent study by researchers at the University of Oxford and Koç University in Istanbul revealed new epigenetic inhibitors that substantially increase the efficiency of induced pluripotent stem cell (iPSC) generation by overcoming intrinsic somatic cell barriers.